CDH2 and cancer: During the acquisition of EMT characteristics, cancer cells lose the expression of proteins that promote cell-cell contact such as E-cadherin and β-catenin, and gain the expression of mesenchymal markers such as Vimentin, Fibronectin, and N-cadherin, leading to enhanced cancer cell migration and invasion.